I recently read a fascinating article in The Independent about a new tool in the fight against childhood obesity. While it seems remarkable, it may not be the ‘silver bullet’ some might hope for, as we will explore.
In July 2025, the scientific community witnessed the unveiling of a remarkable tool capable of predicting a child’s likelihood of developing obesity later in life, using nothing more than a sample of blood. This innovation, the result of an extensive international collaboration and published in Nature Medicine, applies a polygenic risk score (PRS) derived from the DNA of over five million individuals worldwide. It is being celebrated as a significant advance in the ongoing effort to tackle childhood obesity. Yet, the real-world implications for families, healthcare systems, and society as a whole are both complex and far-reaching.
At its core, the obesity prediction tool analyses a child’s genetic profile to estimate their predisposition to obesity. Unlike a diagnosis, this risk assessment does not guarantee future weight gain; it simply identifies children who may be at greater risk. Notably, the tool is reported to be twice as accurate as previous models and, crucially, can be used before the age of five – offering a valuable window for early intervention. In addition to its primary use in children, the tool can also help predict how well obese adults are likely to respond to various weight loss interventions, including lifestyle modifications and pharmaceutical treatments.
There are clear advantages to this approach. Early identification of risk allows preventative action before unhealthy habits are established, potentially averting later health problems. Personalised support can be offered, tailoring interventions to the individual and making them more effective. For many families, understanding their child’s risk may be empowering, enabling them to take control and seek help sooner, rather than waiting for problems to arise. On a public health level, the tool could inform the allocation of resources, ensuring that those at highest risk receive targeted support and that limited resources are used wisely.
However, significant challenges and concerns must be acknowledged. One of the most pressing is the issue of ethnic bias; the tool is currently less accurate for individuals of African ancestry due to underrepresentation in genetic datasets.. This raises concerns about fairness and the potential to widen existing health inequalities. There are also important ethical and privacy questions surrounding the collection and storage of genetic data, particularly when it concerns children. The General Data Protection Regulation (GDPR) provides a legal framework for managing genetic data, but there are ongoing debates about whether current regulations are sufficient to protect children’s rights and autonomy. There are also concerns about who can access this sensitive information – insurers, employers, or educational institutions – and how it might be used.
The risk of stigma is another consideration – labelling children as “at risk” based on their genetics could inadvertently lead to stigmatisation and discrimination, both socially and within institutions. Children may be treated differently by peers, teachers, or even healthcare providers, potentially affecting their self-esteem and mental health. Furthermore, there is the danger of oversimplifying a complex condition: obesity arises from an intricate interplay of genetic, environmental, behavioural, and social factors. Focusing too narrowly on genetic risk may divert attention from these important influences. Although you could argue the common assertion that obesity is caused only by overeating and insufficient exercise is, in itself, also an oversimplification, merely from a different angle.
Finally, the cost and practicalities of widespread implementation – especially in resource-limited settings – should not be underestimated. Widespread implementation may be cost-prohibitive in low-resource settings, potentially widening health disparities.
It is essential to recognise that a genetic risk score signals predisposition, not predestination. While genetics may increase the likelihood of obesity, environmental factors and lifestyle choices play a decisive role. Many children with a high genetic risk will never become obese, just as some with low genetic risk will. Access to healthy food, opportunities for physical activity, mental health support, and a nurturing social environment all profoundly influence outcomes. Therefore, any prediction tool must be used as part of a broader, more holistic approach. Genetics load the gun, but environment and behaviour pull the trigger – or not.
A key question is whether parents will be willing and able to carry out weight loss interventions for their children who are identified as being at risk of obesity. Parents play a pivotal role in this equation. While some may be galvanised to act upon learning their child’s risk, others may face a range of barriers that make it difficult to implement lifestyle changes, even when motivated to support their child’s health.
Structural challenges such as low income, long working hours, and limited access to healthy food can significantly hinder efforts to adopt healthier routines. Emotional and psychological factors also play a role; many parents carry feelings of shame, guilt, or trauma related to their own weight, which can lead to avoidance or a sense of helplessness. Some may fear passing on their struggles to their children. In addition, gaps in knowledge and skills – such as limited nutrition education, lack of cooking confidence, or uncertainty about how to make effective changes – can further complicate matters. Resistance to change may also arise if parents do not believe the interventions are necessary or feel mistrustful of the system, particularly if they perceive judgement.
Conversely, if a child is deemed low risk for obesity based on a genetic test, might some parents misinterpret this result and allow healthy lifestyle habits to slip, believing they are no longer necessary. This false sense of security could lead to complacency, with parents assuming that diet, physical activity, and other health behaviours are less important. However, obesity is influenced by far more than genetics; environmental factors, behavioural patterns, and social conditions all play a significant role. A low genetic risk does not protect a child from the effects of poor nutrition, sedentary behaviour, or emotional stress. Moreover, childhood is a critical period for developing lifelong habits, and neglecting healthy routines can have long-term consequences beyond weight, including impacts on mental health, academic performance, and overall wellbeing. The misunderstanding often stems from a desire for simplicity and certainty, especially when families are under pressure or lack resources. Public health messaging should continue to promote healthy behaviours for all children, regardless of genetic risk, and frame these habits as essential for helping children thrive – not just for avoiding obesity.
In conclusion, the obesity prediction tool represents a powerful new addition to our arsenal in the fight against obesity, but it is not a panacea. To make meaningful progress, we need equitable access to both testing and interventions, holistic support for families, and policies that address the broader determinants of health, such as the food environment and socioeconomic inequalities. Above all, we must approach obesity with empathy and a commitment to empowerment, not blame. Obesity is not merely a medical issue, but a social, economic, and emotional one. Solving it will require much more than a blood test; it demands a comprehensive, compassionate, and coordinated response from all levels of society.
Links
Whittaker, R. & Musto, J. (2025) ‘New tool can predict which children are likely to become obese’, The Independent, 21 July. Available at: https://www.independent.co.uk/news/health/childhood-obesity-tool-test-prediction-b2791700.html#comments-area (Accessed: 21 July 2025).
Smit, R.A.J., Wade, K.H., Hui, Q. et al. (2025) ‘Polygenic prediction of body mass index and obesity through the life course and across ancestries’, Nature Medicine.
Moreno-Grau, S., Vernekar, M., Lopez-Pineda, A. et al. (2024) ‘Polygenic risk score portability for common diseases across genetically diverse populations’, Human Genomics, 18, p. 93.
Burton, W., Twiddy, M., Sahota, P. et al. (2019) ‘Participant engagement with a UK community-based preschool childhood obesity prevention programme: a focused ethnography study’, BMC Public Health, 19, p. 1074.
Nesta (2024) ‘Increase referrals to family-based obesity prevention programmes’. Available at: https://blueprint.nesta.org.uk/intervention/increase-referrals-to-family-based-obesity-prevention-programmes/#:~:text=This%20policy%20would%20involve,programmes.%20Family%2Dbased%20programmes%20are (Accessed: 21 July 2025).
Triggle, N. & Roxby, P. (2025) ‘How do weight-loss drugs like Mounjaro and Wegovy work?’, BBC News. Available at: https://www.bbc.co.uk/news/articles/c981044pgvyo (Accessed: 21 July 2025).
Broadbent, P., Shen, Y., Pearce, A. & Katikireddi, S.V. (2024) ‘Trends in inequalities in childhood overweight and obesity prevalence: a repeat cross-sectional analysis of the Health Survey for England’, Archives of Disease in Childhood, 109(3), pp. 233–239.
Office for Health Improvement and Disparities (2024) ‘Official statistics – Obesity profile: statistical commentary, November 2024’. Available at: https://www.gov.uk/government/statistics/obesity-profile-november-2024-update/obesity-profile-statistical-commentary-november-2024#:~:text=Persistent%20inequalities%20exist%20in,with%20those%20from%20the (Accessed: 21 July 2025).
